Cargando…

An instrument to measure atrial fibrillation knowledge in Chinese patients: validation of the Jessa Atrial fibrillation Knowledge Questionnaire

Background: There is no validated tool to assess patients’ knowledge of oral anticoagulant therapy in atrial fibrillation in China. Methods: Using a standard translation program, the Jessa Atrial fibrillation Knowledge Questionnaire (JAKQ) was translated into Chinese. The reliability of the JAKQ was...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Sijie, Xu, Wenlin, Wu, Shuyi, Desteghe, Lien, Zhang, Feilong, Zhang, Jinhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10321709/
https://www.ncbi.nlm.nih.gov/pubmed/37416065
http://dx.doi.org/10.3389/fphar.2023.1148524
_version_ 1785068670462984192
author Chang, Sijie
Xu, Wenlin
Wu, Shuyi
Desteghe, Lien
Zhang, Feilong
Zhang, Jinhua
author_facet Chang, Sijie
Xu, Wenlin
Wu, Shuyi
Desteghe, Lien
Zhang, Feilong
Zhang, Jinhua
author_sort Chang, Sijie
collection PubMed
description Background: There is no validated tool to assess patients’ knowledge of oral anticoagulant therapy in atrial fibrillation in China. Methods: Using a standard translation program, the Jessa Atrial fibrillation Knowledge Questionnaire (JAKQ) was translated into Chinese. The reliability of the JAKQ was assessed by internal consistency (Cronbach’s α coefficient), repeatability (test-retest reliability), and sensitivity tests. Effectiveness was assessed by hypothesizing that a lower JAKQ score was a risk factor for bleeding. A total of 447 patients with atrial fibrillation (AF) who were hospitalized between July 2019 and December 2021 were studied and followed up. Participants were followed up 1, 3, 6, and 12 months after enrollment. Bleeding during follow-up was recorded. Data were obtained from hospital databases and telephone follow-up. Result: A total of 447 patients with AF completed JAKQ. The mean age of patients was 67.7 ± 10.2 years. The median JAKQ score was 31.3% (12.5–43.8). The Cronbach’s α coefficient of JAKQ was 0.616–0.637, and the test-retest reliability value was 0.902 (p < 0.001). Multivariate logistic regression showed that the higher knowledge level of AF was associated with secondary education or above, an income of more than 2000 yuan, and a history of AF of more than 1 year. Bleeding was associated with a lower JAKQ score, hypertension, and a history of bleeding. Non-bleeding patients on VKA had a better understanding of how often INR should be monitored and what to do if an OAC dose was missed. Conclusion: The Chinese version of JAKQ shows good reliability and validity, indicating that it is a valuable tool for AF and oral anticoagulation (OAC) knowledge assessment. It can be used in clinical practice to guide educational activities and improve the effectiveness and safety of treatment. It was shown that Chinese patients with AF have insufficient knowledge about AF and OAC. Lower JAKQ scores are associated with bleeding, so targeted education is necessary. Targeted educational efforts should focus on patients recently diagnosed with AF and those with lower formal education and income.
format Online
Article
Text
id pubmed-10321709
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-103217092023-07-06 An instrument to measure atrial fibrillation knowledge in Chinese patients: validation of the Jessa Atrial fibrillation Knowledge Questionnaire Chang, Sijie Xu, Wenlin Wu, Shuyi Desteghe, Lien Zhang, Feilong Zhang, Jinhua Front Pharmacol Pharmacology Background: There is no validated tool to assess patients’ knowledge of oral anticoagulant therapy in atrial fibrillation in China. Methods: Using a standard translation program, the Jessa Atrial fibrillation Knowledge Questionnaire (JAKQ) was translated into Chinese. The reliability of the JAKQ was assessed by internal consistency (Cronbach’s α coefficient), repeatability (test-retest reliability), and sensitivity tests. Effectiveness was assessed by hypothesizing that a lower JAKQ score was a risk factor for bleeding. A total of 447 patients with atrial fibrillation (AF) who were hospitalized between July 2019 and December 2021 were studied and followed up. Participants were followed up 1, 3, 6, and 12 months after enrollment. Bleeding during follow-up was recorded. Data were obtained from hospital databases and telephone follow-up. Result: A total of 447 patients with AF completed JAKQ. The mean age of patients was 67.7 ± 10.2 years. The median JAKQ score was 31.3% (12.5–43.8). The Cronbach’s α coefficient of JAKQ was 0.616–0.637, and the test-retest reliability value was 0.902 (p < 0.001). Multivariate logistic regression showed that the higher knowledge level of AF was associated with secondary education or above, an income of more than 2000 yuan, and a history of AF of more than 1 year. Bleeding was associated with a lower JAKQ score, hypertension, and a history of bleeding. Non-bleeding patients on VKA had a better understanding of how often INR should be monitored and what to do if an OAC dose was missed. Conclusion: The Chinese version of JAKQ shows good reliability and validity, indicating that it is a valuable tool for AF and oral anticoagulation (OAC) knowledge assessment. It can be used in clinical practice to guide educational activities and improve the effectiveness and safety of treatment. It was shown that Chinese patients with AF have insufficient knowledge about AF and OAC. Lower JAKQ scores are associated with bleeding, so targeted education is necessary. Targeted educational efforts should focus on patients recently diagnosed with AF and those with lower formal education and income. Frontiers Media S.A. 2023-06-13 /pmc/articles/PMC10321709/ /pubmed/37416065 http://dx.doi.org/10.3389/fphar.2023.1148524 Text en Copyright © 2023 Chang, Xu, Wu, Desteghe, Zhang and Zhang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Chang, Sijie
Xu, Wenlin
Wu, Shuyi
Desteghe, Lien
Zhang, Feilong
Zhang, Jinhua
An instrument to measure atrial fibrillation knowledge in Chinese patients: validation of the Jessa Atrial fibrillation Knowledge Questionnaire
title An instrument to measure atrial fibrillation knowledge in Chinese patients: validation of the Jessa Atrial fibrillation Knowledge Questionnaire
title_full An instrument to measure atrial fibrillation knowledge in Chinese patients: validation of the Jessa Atrial fibrillation Knowledge Questionnaire
title_fullStr An instrument to measure atrial fibrillation knowledge in Chinese patients: validation of the Jessa Atrial fibrillation Knowledge Questionnaire
title_full_unstemmed An instrument to measure atrial fibrillation knowledge in Chinese patients: validation of the Jessa Atrial fibrillation Knowledge Questionnaire
title_short An instrument to measure atrial fibrillation knowledge in Chinese patients: validation of the Jessa Atrial fibrillation Knowledge Questionnaire
title_sort instrument to measure atrial fibrillation knowledge in chinese patients: validation of the jessa atrial fibrillation knowledge questionnaire
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10321709/
https://www.ncbi.nlm.nih.gov/pubmed/37416065
http://dx.doi.org/10.3389/fphar.2023.1148524
work_keys_str_mv AT changsijie aninstrumenttomeasureatrialfibrillationknowledgeinchinesepatientsvalidationofthejessaatrialfibrillationknowledgequestionnaire
AT xuwenlin aninstrumenttomeasureatrialfibrillationknowledgeinchinesepatientsvalidationofthejessaatrialfibrillationknowledgequestionnaire
AT wushuyi aninstrumenttomeasureatrialfibrillationknowledgeinchinesepatientsvalidationofthejessaatrialfibrillationknowledgequestionnaire
AT desteghelien aninstrumenttomeasureatrialfibrillationknowledgeinchinesepatientsvalidationofthejessaatrialfibrillationknowledgequestionnaire
AT zhangfeilong aninstrumenttomeasureatrialfibrillationknowledgeinchinesepatientsvalidationofthejessaatrialfibrillationknowledgequestionnaire
AT zhangjinhua aninstrumenttomeasureatrialfibrillationknowledgeinchinesepatientsvalidationofthejessaatrialfibrillationknowledgequestionnaire
AT changsijie instrumenttomeasureatrialfibrillationknowledgeinchinesepatientsvalidationofthejessaatrialfibrillationknowledgequestionnaire
AT xuwenlin instrumenttomeasureatrialfibrillationknowledgeinchinesepatientsvalidationofthejessaatrialfibrillationknowledgequestionnaire
AT wushuyi instrumenttomeasureatrialfibrillationknowledgeinchinesepatientsvalidationofthejessaatrialfibrillationknowledgequestionnaire
AT desteghelien instrumenttomeasureatrialfibrillationknowledgeinchinesepatientsvalidationofthejessaatrialfibrillationknowledgequestionnaire
AT zhangfeilong instrumenttomeasureatrialfibrillationknowledgeinchinesepatientsvalidationofthejessaatrialfibrillationknowledgequestionnaire
AT zhangjinhua instrumenttomeasureatrialfibrillationknowledgeinchinesepatientsvalidationofthejessaatrialfibrillationknowledgequestionnaire